A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

1997 • 992 citations

Atrophic Gastritis andHelicobacter pyloriInfection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication

1996 • 786 citations

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

1995 • 544 citations

The incidence of Helicobacter pylori infection.

1995 • 393 citations

Is there an optimal degree of acid suppression for healing of duodenal ulcers?

1990 • 351 citations

Treatment of Helicobacter pylori Infection: A Review of the World Literature

1996 • 297 citations

Omeprazole

1991 • 279 citations

Sites of Reaction of the Gastric H,K-ATPase with Extracytoplasmic Thiol Reagents

1997 • 258 citations

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

1996 • 246 citations

The European 13C-urea breath test for the detection of Helicobacter pylori

1991 • 229 citations

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.

1990 • 199 citations

Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.

1995 • 196 citations

Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

1987 • 191 citations

EFFECT OF A CAMPYLOBACTER PYLORI PROTEIN ON ACID SECRETION BY PARIETAL CELLS

1989 • 172 citations

Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.

1995 • 148 citations

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus.

1997 • 131 citations

The continuing development of proton pump inhibitors with particular reference to pantoprazole

1995 • 124 citations

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.

1998 • 120 citations

Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients.

1996 • 103 citations

Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione

1991 • 102 citations

Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.

1996 • 91 citations

Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase.

1994 • 79 citations

Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers.

1994 • 76 citations

Intragastric pH during Treatment with Omeprazole: Role ofHelicobacter pyloriandH. pylori-Associated Gastritis

1996 • 68 citations

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre study

1998 • 59 citations

Effect of Once Daily Intravenous and Oral Omeprazole on 24-Hour Intragastric Acidity in Healthy Subjects

1993 • 57 citations

Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro‐oesophageal reflux disease

1997 • 57 citations

Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs

1986 • 56 citations

Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.

1997 • 54 citations

The Pharmacokinetics of Single and Repeated Once-Daily Doses of 10, 20 and 40mg Omeprazole as Enteric-Coated Granules

1991 • 51 citations

The proton pump inhibitor, E3810, binds to the N-terminal half of the α-subunit of gastric H+,K+-ATPase

1995 • 32 citations

24-Hour Intragastric Acidity and Plasma Gastrin during Long-Term Treatment with Omeprazole or Ranitidine in Patients with Reflux Esophagitis

1991 • 28 citations

Effects of the Proton Pump Inhibitor, E3810, on Gastric Secretion and Gastric and Duodenal Ulcers or Erosions in Rats

1991 • 26 citations

Acid‐inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori‐negative healthy subjects

1998 • 24 citations

Royal Free Hospital Protocol for 24-Hour Intragastric Acidity and Plasma Gastrin Concentration

1990 • 17 citations

Mechanism of Inhibition of H+, K+-ATPase by Sodium 2-((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-lH- benzimidazole (E3810).

1996 • 13 citations

Momentanerfolge und Dauererfolge bei peptischen Geschwüren

1932 • 4 citations

Deleted Work

1955 • 0 citations